AnaptysBio Announced The Pricing Of An Underwritten Offering Of 2,750,498 Shares Of Its Common Stock At A Price Of $36.50 Per Share, Representing A Premium Of Around 10% To Anaptys' Closing Price On Aug. 13, 2024
Portfolio Pulse from Benzinga Newsdesk
AnaptysBio announced the pricing of an underwritten offering of 2,750,498 shares of its common stock at $36.50 per share, which is a 10% premium to its closing price on August 13, 2024.
August 14, 2024 | 9:02 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
AnaptysBio announced an underwritten offering of 2,750,498 shares at $36.50 per share, a 10% premium to its closing price on August 13, 2024.
The offering price being set at a 10% premium to the closing price indicates strong demand and confidence in the stock, which is likely to positively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100